97 related articles for article (PubMed ID: 20857901)
21. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
22. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics.
Nagaraja GM; Othman M; Fox BP; Alsaber R; Pellegrino CM; Zeng Y; Khanna R; Tamburini P; Swaroop A; Kandpal RP
Oncogene; 2006 Apr; 25(16):2328-38. PubMed ID: 16314837
[TBL] [Abstract][Full Text] [Related]
23. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
24. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
25. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of acidic proteins with progression in the MCF10 model of human breast disease.
Buchanan NS; Zhao J; Zhu K; Patwa TH; Miller FR; Lubman DM
Int J Oncol; 2007 Oct; 31(4):941-9. PubMed ID: 17786328
[TBL] [Abstract][Full Text] [Related]
27. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.
Bae SM; Lee CH; Cho YL; Nam KH; Kim YW; Kim CK; Han BD; Lee YJ; Chun HJ; Ahn WS
Gynecol Oncol; 2005 Oct; 99(1):26-35. PubMed ID: 16051329
[TBL] [Abstract][Full Text] [Related]
28. Quantitative proteomic profiling of matched normal and tumor breast tissues.
Sutton CW; Rustogi N; Gurkan C; Scally A; Loizidou MA; Hadjisavvas A; Kyriacou K
J Proteome Res; 2010 Aug; 9(8):3891-902. PubMed ID: 20560667
[TBL] [Abstract][Full Text] [Related]
29. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
30. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
[TBL] [Abstract][Full Text] [Related]
32. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
33. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
34. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma.
Liang X; Zhao J; Hajivandi M; Wu R; Tao J; Amshey JW; Pope RM
J Proteome Res; 2006 Oct; 5(10):2632-41. PubMed ID: 17022634
[TBL] [Abstract][Full Text] [Related]
35. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
[TBL] [Abstract][Full Text] [Related]
36. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis.
Turhani D; Krapfenbauer K; Thurnher D; Langen H; Fountoulakis M
Electrophoresis; 2006 Apr; 27(7):1417-23. PubMed ID: 16568407
[TBL] [Abstract][Full Text] [Related]
37. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
38. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
39. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
[TBL] [Abstract][Full Text] [Related]
40. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
